Assembly Biosciences, Inc. (ASMB) Operating margin 2017–2025
Assembly Biosciences, Inc. (ASMB) operating margin by fiscal year — reported operating income divided by reported revenue.
-16.8%FY2025 · since FY2017: -579.1% → -16.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -16.8% | +142.5 pp |
| FY2024 | -159.3% | +743.2 pp |
| FY2023 | -902.5% | — |
| FY2021 | -2121.7% | -2039.8 pp |
| FY2020 | -81.9% | +561.6 pp |
| FY2019 | -643.4% | -17.0 pp |
| FY2018 | -626.4% | -47.3 pp |
| FY2017 | -579.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice